Trade Mark Journal No.2026/021 22 May 2026

WO0000001916459 (1)

Office of origin: United States of America

Date of International Registration:30 March 2026
Date of designation in the UK: 30 March 2026
Image for mark 1916459 REGENOSOME

International priority date claimed: 30 September 2025 (United States of America) (99421141)
Class 1
Biologically derived ingredients and nanoparticles, namely, exosomes and extracellular vesicles for use in the formulation and manufacture of injectable biologic drug preparations.

Rion Medical Aesthetics Inc.

Representative: Timothy Sitzmann Winthrop & Weinstine, P.A., 225 South Sixth Street,, Capella Tower Suite 3500, Minneapolis MN 55402, UNITED STATES OF AMERICA